Microfluidics-Based Pathogen Detection: A Highly Sensitive Molecular Detection Platform for Robust and Facile Diagnosis of Middle East Respiratory Syndrome (MERS) Corona Virus (Adv. Healthcare Mater. 17/2016)
H. Lee and co-workers demonstrate a definitive molecular diagnosis platform (DhITACT-TR) for rapid and accurate detection of MERS coronavirus on page 2168. DhITACT-TR offers a robust diagnosis of target RNA pathogens in pseudo-serum specimens with minimum liquid handling as compared to conventional PCR analysis. In addition, a definitive diagnostic result can be achieved within 30 min by an optical detection.